Loading...

Christopher Weil & Co Core Investment

CWCFXβ€’NASDAQ
NaN
NaN
$11.80
$-0.01(-0.08%)
U.S. Market is Open β€’ 09:47

CWCFX News Today: Stay Updated with the Latest Christopher Weil & Co Core Investment News in Real Time

Find CWCFX news now at Meyka AI. Stay informed with the latest Christopher Weil & Co Core Investment stocks updates, including price news, market analysis, and expert insights.

MLEC Insider Filing: Core Daniel Joaquin Director Stake, April 22, 2026
πŸ“… in about 5 hours

MLEC Insider Filing: Core Daniel Joaquin Director Stake, April 22, 2026

Director Core Daniel Joaquin files initial ownership of 933 ordinary shares in Moolec Science (MLEC) valued at $6,661.62 on April 15, 2026.

Read more
Canadian Flight Prices Jump April 22: Fuel Crisis Hits Travelers
πŸ“… in about 5 hours

Canadian Flight Prices Jump April 22: Fuel Crisis Hits Travelers

Canadian flight prices rise 2.9% in March 2026 for the first time in 2 years amid fuel crisis and baggage fee hikes.

Read more
DW8.AX Stock Surges 2400% in April 2026 on ASX
πŸ“… in about 5 hours

DW8.AX Stock Surges 2400% in April 2026 on ASX

DW8.AX stock price hits A$0.025 with massive 2400% gain. Beverage tech platform shows extreme volatility on ASX.

Read more
GNRSU Stock Crashes 99.99% on Pink Sheets, Greenrose Holdings Faces Delisting Risk
πŸ“… in about 5 hours

GNRSU Stock Crashes 99.99% on Pink Sheets, Greenrose Holdings Faces Delisting Risk

GNRSU stock plummets 99.99% to $0.000001 on PNK exchange. Greenrose Holdings faces severe liquidity crisis with market cap of just $13.

Read more
GRBK Insider Trading: Cox Jeffery Dean Restricted Stock Units Filing April 22, 2026
πŸ“… in about 5 hours

GRBK Insider Trading: Cox Jeffery Dean Restricted Stock Units Filing April 22, 2026

Green Brick Partners insider Jeffery Dean files restricted stock units ownership. GRBK rated B+ by Meyka AI. SEC filing details.

Read more
Travere Kidney Drug Approved April 22: FDA Flexes Authority
πŸ“… in about 5 hours

Travere Kidney Drug Approved April 22: FDA Flexes Authority

Travere’s Filspari approved by FDA April 22 for rare kidney disease, opening a $3B market opportunity despite limited efficacy data.

Read more
SO Stock: Morgan Stanley Maintains Underweight Rating April 2026
πŸ“… in about 5 hours

SO Stock: Morgan Stanley Maintains Underweight Rating April 2026

Morgan Stanley maintains Underweight rating on Southern Company (SO), lowering price target to $92 from $94 on April 21, 2026.

Read more
Tesla Q1 Earnings Preview: Robotaxis, AI Spending Surge, and Analyst Forecast Revisions
πŸ“… in about 5 hours

Tesla Q1 Earnings Preview: Robotaxis, AI Spending Surge, and Analyst Forecast Revisions

Tesla is set to report its Q1 2026 earnings in late April 2026, and investor attention is unusually intense this quarter. The company is no longer viewed only as an electric vehicle maker. It is now being closely tracked as an AI and autonomous technology leader. Expectations are high, but so are concerns. Recent data…

Read more
AAPL Stock April 22: Tim Cook Steps Down, John Ternus Takes Over
πŸ“… in about 5 hours

AAPL Stock April 22: Tim Cook Steps Down, John Ternus Takes Over

Tim Cook steps down as Apple CEO; John Ternus takes over September 2026. Historic leadership transition with market implications.

Read more

CWCFX News FAQ